Deciphera Pharmaceuticals, Inc. Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Deciphera Pharmaceuticals, Inc. had Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount of $78.10 million as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized · last filed 2024-05-10
- 2024-03-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $78.10M.
- 2023-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $54.50M.
- 2023-09-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $65.60M.
- 2023-06-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $72.70M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount |
|---|---|
| 2024-03-31 | $78.10M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $54.50M 10-K · filed 2024-02-07 |
| 2023-09-30 | $65.60M 10-Q · filed 2023-10-30 |
| 2023-06-30 | $72.70M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $82.40M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $66.60M 10-K · filed 2023-02-07 |
| 2022-09-30 | $76.90M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $84.60M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $98.10M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $101.10M 10-K · filed 2022-02-08 |
| 2021-09-30 | $106.80M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $121.70M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $129.30M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $85.00M 10-K · filed 2021-02-09 |
| 2020-09-30 | $92.60M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $105.00M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $102.40M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $60.80M 10-K · filed 2020-03-09 |
| 2019-09-30 | $52.40M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $48.60M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $46.80M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $27.20M 10-K · filed 2019-03-14 |
| 2018-09-30 | $29.50M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $25.10M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $21.90M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $8.80M 10-K · filed 2018-03-28 |